Is peptide receptor radionuclide therapy an option after liver transplantation in progressive metastatic neuroendocrine tumors?

被引：0
|
作者：
Kulkarni, Harshad [1 ]
Kaemmerer, Daniel [2 ]
Hoersch, Dieter [3 ]
Hommann, Merten [2 ]
Baum, Richard [1 ]
机构：
[1] Zent Klin, Mol Radiotherapy & Mol Imaging, Bad Berka, Germany
[2] Zent Klin, Gen & Visceral Surg, Bad Berka, Germany
[3] Zent Klin, Internal Med Gastroenterol & Endocrinol, Bad Berka, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1177
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors
    Yordanova, Anna
    Ahrens, Harriet
    Feldmann, Georg
    Brossart, Peter
    Gaertner, Florian C.
    Fottner, Christian
    Weber, Matthias M.
    Ahmadzadehfar, Hojjat
    Schreckenberger, Mathias
    Miederer, Matthias
    Essler, Markus
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (05) : E329 - E335
  • [42] SSTR-positive neuroendocrine tumors: peptide receptor radionuclide therapy
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 : S66 - S69
  • [43] Alpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
    Bhimaniya, Sudhir
    Shah, Hina
    Jacene, Heather A.
    PET CLINICS, 2024, 19 (03) : 341 - 349
  • [44] The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors
    Hindie, Elif
    Baudin, Eric
    Hicks, Rodney J.
    Taieb, David
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (04) : 522 - 524
  • [45] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues
    Bodei, L.
    Pepe, G.
    Paganelli, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 347 - 351
  • [46] Peptide Receptor Radionuclide Therapy An emrirciing treatment for gastrointestinal neuroendocrine tumors
    Myers, Adria
    Chitwood, Holly Renea
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2020, 24 (02) : 129 - 133
  • [47] Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors
    Ramage, John
    Naraev, Boris G.
    Halfdanarson, Thorvardur R.
    SEMINARS IN ONCOLOGY, 2018, 45 (04) : 236 - 248
  • [48] Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?
    Hope, Thomas A.
    Pavel, Marianne
    Bergsland, Emily K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (24) : 2818 - +
  • [49] Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting
    Kalshetty, Ashwini
    Ramaswamy, Anant
    Ostwal, Vikas
    Basu, Sandip
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1143 - 1149
  • [50] Salvage peptide receptor radionuclide therapy in patients with progressive neuroendocrine tumors: a systematic review and meta-analysis
    Kim, Yong-il
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (04) : 451 - 458
12345